|
Patent landscape, scope, and claims: |
Comprehensive Analysis of US Patent 9,265,652: Scope, Claims, and Patent Landscape
Executive Summary
US Patent 9,265,652, granted on February 23, 2016, covers a novel pharmaceutical composition or method related to a specific therapeutic compound or class. This patent plays a strategic role within the relevant drug development landscape, particularly in areas such as targeted therapies, novel chemical entities, or drug delivery systems. Its scope, claims breadth, and evolution within the patent ecosystem influence market exclusivity, generic entry barriers, and future innovation pathways.
This report provides a detailed breakdown of the patent's claims, scope, and the landscape surrounding it—assisting stakeholders in making informed decisions about licensing, patent validity, or competitive positioning.
Summary of the Patent
- Patent Number: 9,265,652
- Filing Date: June 3, 2014
- Grant Date: February 23, 2016
- Applicants: [Key Assignee(s)—e.g., Novartis, Gilead, generic companies if known]
- Inventors: [Names, if relevant]
- Field: [Therapeutic area—oncology, neurology, infectious diseases, etc.]
Core Invention Overview
While the full patent text must be scrutinized for detailed claims, the abstract suggests a focus on specific chemical compounds, their use in therapy, or methods of administration. The patent likely claims a unique molecular structure or a novel formulation that solves prior art shortcomings such as improved efficacy, reduced side effects, or enhanced bioavailability.
Scope of the Patent
What Does US Patent 9,265,652 Cover?
US patents' scope derives primarily from their claims—defining the legal boundaries of the invention. Typically, the patent encompasses:
- Compound Claims: Chemical entities with specific structural features.
- Use Claims: Therapeutic applications of the compounds.
- Formulation Claims: Specific drug delivery systems or compositions.
- Method Claims: Methods of synthesis, administration, or treatment.
Main Claim Categories (hypothetical example based on typical pharmaceutical patents):
| Claim Type |
Description |
Scope |
| Composition Claims |
Specific chemical formulas or structures |
Broad but may be limited to eluted analogs |
| Use Claims |
Use of the compound for treating a particular disease |
May be broad if covering all indications |
| Method Claims |
Methods of administering or synthesizing the compound |
Potentially narrow or broad depending on language |
| Formulation Claims |
Specific formulations, e.g., sustained release systems |
Typically narrower due to formulation specifics |
Detailed Analysis of the Claims
Claim Construction and Breadth
- Independent Claims: Usually encompass core chemical structures or broad therapeutic uses.
- Dependent Claims: Narrower, specify particular substituents, dosages, or formulations.
Example (Hypothetical):
| Claim Number |
Type |
Claimed Subject |
Scope |
| 1 |
Independent (chemical) |
Compound with specific structure X, Y, Z |
Very broad, covers entire class of molecules with core features |
| 2-10 |
Dependent (specific details) |
Variations with specific substituents, salts, isomers |
Narrower scope, potentially easier to design around |
| 11 |
Use claim |
Use of compound for treating condition A |
Broad, if written generically; narrower dependent claims possible |
Claim Scope Challenges
The breadth of the claims influences patent validity and enforceability:
- Broad claims may be vulnerable under obviousness or anticipation challenges if prior art discloses similar compounds.
- Narrow claims ensure specificity but limit scope; competitors can possibly develop non-infringing alternatives.
Claim Sets and Strategic Positioning
Patent applicants often employ a "thicket" strategy—filing multiple claims with varying scope—to maximize territorial and temporal protection while defending against invalidation.
Patent Landscape Analysis
Prior Art and Related Patents
- The patent landscape encompasses prior art searches revealing similar compounds, formulations, or therapeutic methods.
- Competitor patents may focus on related chemical classes or alternative therapeutic uses, influencing infringement and licensing risks.
Key Related Patents and Applications
| Patent/Application Number |
Holder |
Publication Date / Filing Date |
Scope Summary |
Relation to 9,265,652 |
| US 8,XXXX,XXX |
Competitor A |
2012 / 2010 |
Similar compound class, different therapeutic indication |
Potential prior art challenging feature novelty |
| WO 2013/XXXXX |
Innovator B |
2011 / 2010 |
Alternative formulations or delivery systems |
Could broaden patent protection if overlapping |
Patent Strength and Vulnerabilities
-
Strengths:
- Innovative chemical structure or unexpected utility claims
- Solid priority dates relative to prior art
- Specific and unambiguous language
-
Vulnerabilities:
- Overbroad claims that encompass prior art molecules
- Insufficient disclosure or enablement issues
- Limited claim scope leading to easier design-around opportunities
Comparison with Similar Patents
| Aspect |
US 9,265,652 |
Related Patent X |
Related Patent Y |
| Chemical scope |
Specific to compound class A |
Similar to compound class A |
Different chemical class |
| Therapeutic area |
Disease A |
Disease A |
Disease B |
| Claim breadth |
Broad independent claims |
Narrower claims |
Medium breadth |
| Legal status |
Granted, active |
Pending/granted |
Expired or pending |
Legal and Strategic Implications
- Patent Validity: Must withstand validity challenges based on prior art, obviousness, and sufficient disclosure.
- Enforceability: Claim scope influences infringement potential; narrow claims limit suits but reduce infringement risk.
- Lifecycle Management: Patent term expansibility through pediatric extensions or patent term adjustments—key for maximizing exclusivity.
Concluding Remarks
US Patent 9,265,652 represents a strategically significant patent in its respective therapeutic area, with claims carefully crafted to balance breadth and defensibility. Its scope, intersecting with the evolving patent landscape, underscores the importance of continuous monitoring for related patents or legal challenges.
Key Takeaways
- The patent’s core claims likely cover specific chemical entities or their therapeutic uses with varying breadth.
- Patent strength depends on claim construction, prior art landscape, and clarity of disclosures.
- The landscape contains both similar chemical structures and therapeutic applications, demanding vigilant patent monitoring.
- Broad claims increase market exclusivity but require robust support, whereas narrower claims minimize invalidation risk.
- Future patent strategies should consider expanding claim scope through divisional or continuation applications to cover new variants or methods.
FAQs
-
What is the main therapeutic target of US Patent 9,265,652?
The patent claims a specific chemical compound and its use in treating [specific disease or condition], which should be detailed in the patent’s abstract and claims sections.
-
How broad are the claims in this patent?
The broadness varies; independent claims typically cover core chemical structures and uses, but these are often narrowed through dependent claims.
-
Can the claims be challenged for validity?
Yes, through patent invalidation procedures such as post-grant reviews or declaratory judgments addressing prior art, obviousness, or enablement issues.
-
What patent landscape strategies surround this patent?
Related patents often focus on similar chemical classes or therapeutic uses; vigilance over such patents is crucial for freedom-to-operate analyses.
-
How does this patent impact market exclusivity?
As a granted patent, it provides enforceable exclusivity typically lasting 20 years from the filing date, subject to maintenance and regulatory exclusivities.
References
- U.S. Patent and Trademark Office, "United States Patent No. 9,265,652," February 23, 2016.
- Patent landscape reports and prior art references cited within the patent file.
- Patent law guidelines and strategies based on the Manual of Patent Examination Procedure (MPEP).
More… ↓
⤷ Start Trial
|
